Joseph Fralin  Woody net worth and biography

Joseph Woody Biography and Net Worth

Director of Avita Medical

Mr. Woody is a seasoned healthcare executive with more than two decades of leadership experience across the medical technology sector, most recently serving as CEO of Avanos Medical from 2017 to 2024, and previously, as President and CEO of Acelity Holdings. His background spans multiple senior executive roles, including with Covidien and Smith & Nephew. Across his storied professional career, Mr. Woody also served on the Board of Directors of AdvaMed, Inc., the largest trade association in the U.S. for the medical device, diagnostics, and digital health technology sectors, for over a decade.

What is Joseph Fralin Woody's net worth?

The estimated net worth of Joseph Fralin Woody is at least $846.20 thousand as of June 9th, 2026. Woody owns 107,961 shares of Avita Medical stock worth more than $846,198 as of August 10th. This net worth estimate does not reflect any other investments that Woody may own. Learn More about Joseph Fralin Woody's net worth.

How do I contact Joseph Fralin Woody?

The corporate mailing address for Woody and other Avita Medical executives is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. Avita Medical can also be reached via phone at (833) 462-8482 and via email at [email protected]. Learn More on Joseph Fralin Woody's contact information.

Has Joseph Fralin Woody been buying or selling shares of Avita Medical?

Joseph Fralin Woody has not been actively trading shares of Avita Medical during the last ninety days. Most recently, on Tuesday, June 9th, Joseph Fralin Woody bought 10,000 shares of Avita Medical stock. The stock was acquired at an average cost of $4.19 per share, with a total value of $41,900.00. Following the completion of the transaction, the director now directly owns 102,761 shares of the company's stock, valued at $430,568.59. Learn More on Joseph Fralin Woody's trading history.

Who are Avita Medical's active insiders?

Avita Medical's insider roster includes Suzanne Crowe (Director), Michael Perry (CEO), and Joseph Woody (Director). Learn More on Avita Medical's active insiders.

Are insiders buying or selling shares of Avita Medical?

In the last year, Avita Medical insiders bought shares 10 times. They purchased a total of 64,200 shares worth more than $281,190.00. The most recent insider tranaction occured on June, 9th when Director Joseph Fralin Woody bought 10,000 shares worth more than $41,900.00. Insiders at Avita Medical own 2.2% of the company. Learn More about insider trades at Avita Medical.

Information on this page was last updated on 6/9/2026.

Joseph Fralin Woody Insider Trading History at Avita Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2026Buy10,000$4.19$41,900.00102,761View SEC Filing Icon  
6/9/2026Buy5,200$4.00$20,800.00107,961View SEC Filing Icon  
6/3/2026Buy10,000$4.09$40,900.0092,761View SEC Filing Icon  
6/1/2026Buy10,000$4.30$43,000.0010,000View SEC Filing Icon  
See Full Table

Joseph Fralin Woody Buying and Selling Activity at Avita Medical

This chart shows Joseph Fralin Woody's buying and selling at Avita Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avita Medical Company Overview

Avita Medical logo
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Read More

Today's Range

Now: $7.92
Low: $7.39
High: $8.35

50 Day Range

MA: $4.47
Low: $3.91
High: $7.77

2 Week Range

Now: $7.92
Low: $3.22
High: $8.35

Volume

421,400 shs

Average Volume

301,972 shs

Market Capitalization

$243.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86